Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008

WALTHAM, Mass., June 6 /PRNewswire-FirstCall/ -- Inverness Medical
Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid
diagnostic products for the consumer and professional markets, today
announced that it will attend the 7th Annual Needham & Company, LLC
Biotechnology & Medical Technology Conference being held June 11-12, 2008
at the New York Palace Hotel in New York City. Jon Russell, Vice President,
Finance, will present on Thursday, June 12 at 10:30am.

More information about the 7th Annual Needham & Company, LLC
Biotechnology and Medical Technology Conference can be found at
http://www.needhamco.com.

More information about Inverness Medical Innovations can be found at
http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring
and health management, Inverness Medical Innovations enables individuals to
take charge of improving their health and quality of life. A global leader
in rapid point-of-care diagnostics, Inverness' products, as well as its new
product development efforts, focus on infectious disease, cardiology,
oncology, drugs of abuse and women's health. Inverness is headquartered in
Waltham, Massachusetts.

See Also:

• Recurring Yeast Infections and Alcoholic Beverages



• Weight Loss Options: The Liposuction Procedure



• IMULAN Initiates Feline Leukemia Virus (FeLV) Study



• Mueller's(R) Pasta Partners With American Diabetes Association for The 'Tour De Cure'



• Encouragement For Your Cardiomyopathy Diagnosis!

[Via Healthcare]